Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eravacycline vs Meropenem in cIAI
NCT02784704Phase 3Completed
- Sponsor
- Tetraphase Therapeutics
- Start
- Oct 2016
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 11
01
Overview
Phase 3, randomised, double-blind trial of eravacycline in Intra-abdominal infection (IAI) (2 arms), sponsored by Tetraphase Therapeutics. Primary endpoint: Clinical Response at the Test-of-Cure (TOC) Visit. Started Oct 2016; status: completed.
02
Drugs
eravacycline
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT02784704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02784704.